drugset / Trial / NCT00004840

Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants

NCT00004840

RandomizedDouble-blindTreatment

Summary

OBJECTIVES: I. Assess the efficacy and safety of antenatal administration of thyrotropin-releasing hormone to women in premature labor to improve pulmonary outcomes in preterm infants.

Timeline

Start
1998-05
Primary completion
Completion
1998-06

Drugs

EvaluationDrugModalityDoseRoute
Subject PROTIRELIN Protein / enzyme biologic Intravenous